TSXV:XRTX (Canada)  
XORTX Therapeutics Inc logo

XORTX Therapeutics Inc

C$ 1.26 (0%) Dec 8
P/E:
2.42
P/B:
1.53
Market Cap:
C$ 18.13M ($ 13.34M)
Enterprise V:
C$ 6.10M ($ 4.49M)
Volume:
-
Avg Vol (2M):
8.22K
Also Trade In:
Volume:
-
Market Cap C$:
18.13M
Market Cap $:
13.34M
PE Ratio:
2.42
Avg Vol (2-Month):
8.22K
Enterprise Value C$:
6.10M
Enterprise Value $:
4.49M
PB Ratio:
1.53

Business Description

Description
XORTX Therapeutics Inc is a clinical-stage biotechnology company. The company focused on developing drug therapies for orphan diseases like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.
Name Current Vs Industry Vs History
Cash-To-Debt 95.75
Equity-to-Asset 0.72
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 53.82
9-Day RSI 53.32
14-Day RSI 51.66
6-1 Month Momentum % -45.59
12-1 Month Momentum % -61.32

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.66
Quick Ratio 6.66
Cash Ratio 6.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -34.3